All Latest News
-
Adare Pharma Solutions Announces Appointment of Tom Sellig as Chief Executive Officer
Sellig Will Drive Enhanced Customer Service and Go-To-Market Strategy LAWRENCEVILLE, New Jersey, January 6, 2022 – Adare Pharma Solutions ("Adare"), a global, technology-driven contract development and manufacturing organization (CDMO),... Learn More
-
Adare Pharma Solutions Acquires Frontida BioPharm to Expand Leading CDMO Offerings
Lawrenceville, NJ, December 1, 2021 – Adare Pharma Solutions (“Adare”), a technology-driven contract development and manufacturing organization (CDMO), announced today the acquisition of Frontida BioPharm (“Frontida”), a... Learn More
-
The Challenges of Formulating Medicines for Children
Developing medications for adults is a difficult and complex undertaking on its own. But developing medications for children increases the difficulty and complexity many times over. Scientists face additional challenges when developing... Learn More
-
Adare Pharma Solutions Expands Executive Leadership Team
New Chief Scientific Officer and Chief Commercial Officer Hired to Further Accelerate Growth and Differentiate Adare as CDMO Lawrenceville, NJ, May 25, 2021 – Adare Pharma Solutions, a specialized Contract Development Manufacturing... Learn More
-
Adare Pharma Solutions Appoints Ludger Roedder as President, Adare Biome
Lawrenceville, NJ, April 20, 2021 - Adare Pharma Solutions is excited to announce that Ludger Roedder has joined the organization as President of Adare Biome. As Adare has committed to growing its Pharma Solutions and Microbiome... Learn More
-
Adare Pharma Solutions Opens New Small-Scale Laboratory to Offer Faster and More Efficient Development Capabilities to Clients
New laboratory brings customizable, flexible systems to expedite formulation and process development services Provides customers more early stage development capacity Lawrenceville, NJ January 26, 2021 Adare Pharma Solutions,... Learn More
-
THOMAS H. LEE PARTNERS AND FRAZIER HEALTHCARE PARTNERS ACQUIRE ADARE
Boston, MA and Seattle, WA - September 22, 2020 Transaction includes specialty CDMO business, including pharmaceutical technology and microbiome businesses Thomas H. Lee Partners, L.P. (“THL”) and Frazier Healthcare Partners... Learn More
-
Adare Pharmaceuticals, Inc. Acquires Orbis Biosciences
Lawrenceville, NJ, and Lenexa, KS - May 4, 2020 Kansas-based pharmaceutical technology company develops customized formulations and intellectual property Deal includes platforms that can be dosed in oral, injectable and otic (ear)... Learn More
-
Adare Pharmaceuticals and NLS Pharmaceutics collaborate to develop mazindol controlled release (CR) for the treatment of ADHD and narcolepsy
Lawrenceville, NJ & Switzerland - January 13, 2020 Adare Pharmaceuticals, Inc. (Adare) and NLS Pharmaceutics Ltd. (NLS) announced today a collaboration to develop mazindol (MZD) CR product candidates for the treatment of narcolepsy... Learn More
-
Adare acquires Egalet’s proprietary “Parvulet®” technology platform
Princeton, NJ & Wayne, PA - April 15, 2019 Adare Pharmaceuticals, Inc. today announced that it has entered into an agreement with Egalet Corporation (OTCQX: ZCOR), to acquire global rights of the “ParvuletTM” technology platform... Learn More
